Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2360592A - Polyacrylic acid based ophthalmic compositions - Google Patents
[go: Go Back, main page]

AU2360592A - Polyacrylic acid based ophthalmic compositions - Google Patents

Polyacrylic acid based ophthalmic compositions

Info

Publication number
AU2360592A
AU2360592A AU23605/92A AU2360592A AU2360592A AU 2360592 A AU2360592 A AU 2360592A AU 23605/92 A AU23605/92 A AU 23605/92A AU 2360592 A AU2360592 A AU 2360592A AU 2360592 A AU2360592 A AU 2360592A
Authority
AU
Australia
Prior art keywords
agents
compositions
ophthalmic compositions
polyacrylic acid
acid based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23605/92A
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRE EUROPHTA SA
Original Assignee
LABORATOIRE EUROPHTA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9414887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2360592(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LABORATOIRE EUROPHTA SA filed Critical LABORATOIRE EUROPHTA SA
Publication of AU2360592A publication Critical patent/AU2360592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Novel pharmaceutical compositions for ophthalmic use. The invention especially concerns ophthalmic compositions for use by instillation characterized in that they contain an active ingredient selected from the group consisting of $g(b) blocking agents, ocular anti-hypertension agents, healing agents, anti-allergic agents, anti-bacterial agents, fungicide agents and anti-viral agents as well as prodrugs or their possible biological precursors, in combination with a gelling acrylic acid polymer and a base agent to obtain a fluid aqueous gel having a pH of between 6.5 and 8. The compositions according to the invention can be used to treat various pathological ocular conditions.
AU23605/92A 1991-07-10 1992-07-10 Polyacrylic acid based ophthalmic compositions Abandoned AU2360592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9108625A FR2678832B1 (en) 1991-07-10 1991-07-10 NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED RESORPTION AND METHODS OF PREPARING THE SAME.
FR9108625 1991-07-10

Publications (1)

Publication Number Publication Date
AU2360592A true AU2360592A (en) 1993-02-11

Family

ID=9414887

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23605/92A Abandoned AU2360592A (en) 1991-07-10 1992-07-10 Polyacrylic acid based ophthalmic compositions

Country Status (8)

Country Link
EP (1) EP0594760B1 (en)
AT (1) ATE165732T1 (en)
AU (1) AU2360592A (en)
DE (1) DE69225405T2 (en)
ES (1) ES2118824T3 (en)
FI (1) FI940081A7 (en)
FR (1) FR2678832B1 (en)
WO (1) WO1993000887A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401109D0 (en) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
SE9401108D0 (en) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE19614823A1 (en) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000001365A1 (en) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
IN185228B (en) * 1999-02-03 2000-12-09 Bakulesh Mafatlal Dr Khamar
FR2860718B1 (en) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues NOVEL FORMULATION AND ITS APPLICATIONS IN THE COSMETIC OR PHARMACEUTICAL FIELDS
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
US9173915B1 (en) * 2014-10-10 2015-11-03 Peter F. Kador Antioxidant eye drops
WO2025163023A1 (en) * 2024-01-31 2025-08-07 Laboratorios Salvat, S.A. Ophthalmic formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
WO1990013284A1 (en) * 1989-04-29 1990-11-15 Fisons Plc Pharmaceutical composition containing sodium cromoglycate

Also Published As

Publication number Publication date
FI940081A0 (en) 1994-01-07
FI940081L (en) 1994-03-07
DE69225405T2 (en) 1998-12-03
FR2678832B1 (en) 1995-03-17
EP0594760B1 (en) 1998-05-06
FI940081A7 (en) 1994-03-07
FR2678832A1 (en) 1993-01-15
WO1993000887A1 (en) 1993-01-21
EP0594760A1 (en) 1994-05-04
ES2118824T3 (en) 1998-10-01
ATE165732T1 (en) 1998-05-15
DE69225405D1 (en) 1998-06-10

Similar Documents

Publication Publication Date Title
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
CA2225808A1 (en) Silver-based pharmaceutical compositions
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
ATE300936T1 (en) APPLICATION OF BORAL-POLYOL COMPLEXES FOR OPHTHALMIC MEDICINAL COMPOSITIONS
US3755561A (en) Bactericidal contact lens solution
CA2251982A1 (en) Ophthalmic compound with extended dwell time on the eye
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
KR100260061B1 (en) Vitamin e drop
ATE173578T1 (en) IMPLANTABLE MOLDED BODY FOR ADMINISTRATION OF ACTIVE INGREDIENTS TO PLANTS
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
BR9914128A (en) Antibiotic compositions for treatment of the eye, ear and nose
ES2141736T3 (en) GEL, ESPECIALLY FOR EYE THERAPEUTIC USE.
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
DK0594770T3 (en) Ophthalmological mixtures
NZ500300A (en) Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
ES2026935T3 (en) PLANT TREATMENT PROCEDURE AGAINST BACTERIAL DISEASES.
EP0373771A3 (en) New pharmaceutical uses for cystatins
NO940064L (en) Eye preparation on polyacrylic acid basis
SE9302203D0 (en) COMPOSITION FOR OPHTHALMIC USE
CA2300806C (en) Dexamethasone gel
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
MXPA02003731A (en) Novel fusidic acid derivatives.
DE69109119D1 (en) EXTENSION FORMULA FORM WITH SUPPORTING PROPERTIES FOR AGRICULTURAL PRODUCTS.
MD371C2 (en) Fungicidal agent